SCHEMBL21960132

SCHEMBL21960132

C=C1CC2CCC(C1)N2C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
AGTR2 P50052 5/20 0.51
CYP2C19 P33261 1/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45
APH1A Q96BI3 1/20 0.45
PSENEN Q9NZ42 1/20 0.45
HDAC1 Q13547 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CACNA1G O43497 1/20 0.44
CACNA1H O95180 1/20 0.44
CACNA1I Q9P0X4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346956 1.00 HTR2C (0.53) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL25125018 0.88 HTR2C (0.61) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL154134 0.87 HTR2C (0.55) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL12094663 0.87 HTR2C (0.55) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL13791959 0.84 HTR2C (0.49) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL14336080 0.84 HTR2C (0.57) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL16707782 0.83 HTR2C (0.51) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL1200003 0.83 HTR2C (0.51) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL12873783 0.83 HTR2C (0.51) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL15191600 0.82 HTR2C (0.56) HTR2CSMN1; SMN2NPC1RAB9AAGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020079106-A1 CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-04-23 WO disclosed